RESUMO
Objective To improve the quality of prescriptions and promote the rational drug application of Dingqing Tablets by investigating the outpatient prescriptions in a tertiary A hospital. Methods A total of 4 796 prescriptions of outpatient pharmacy patients from August 1, 2020 to August 1, 2021 were extracted from the hospital information system by the hospital information software, focusing on the analysis of indications, usage and dosage, drug interaction, etc. Results 10 departments including hematology department and geriatrics department were used Dingqing Tablets, and the irrationality was mainly manifested in the superposition of drug flavors and drug interactions. Conclusion Dingqing tablets were widely used in clinic and had remarkable curative effect. However, there are certain risks in the use of Dingqing tablets. It is necessary to add medication education and supervision to promote the safe and rational use of drugs in clinic.
RESUMO
Objective To study the rationality about the application of clinical medication for diabetic microcirculation disorderturbance in a general hospital of level Ⅱ in Changshu. Methods Three hundred and fifty-nine patients with T2DM who received the clinical pathway treatment were enrolled in this study in a general hospital of level II in Changshu from July to December 2016. The statistical analysis was performed on the clinical application of microcirculation-improving drugs. The selection of microcirculation-improving drugs ,the drug utilization index(DUI),the intensity of microcirculation-improving drugs and the rate of drug combination were used as the evaluation criteria. Results The utilization rate of microcirculation-improving drugs was 94.43 %,and the combination rate was 73.75 %.The selection of microcirculation-improving drugs was the traditional Chinese medicine injections which activated blood circulation and vasodilators,with the DUI ranged from 0.9 to 1.1,and the intensity of microcirculation-improving drugs was 177.82 DDD. Conclusion The application of the clinical medication for the diabetic microcirculation disturbance was not standard,as a result,the indications of medication were not clear,and the indications of drug combination were not controlled strictly,the therapeutic regimen was unreasonable,and further management should be strengthened.
RESUMO
Drug Information Centers (DIC) have an important place in the health care process since they provide independent and updated information. A search was developed in Medline, Science Direct, Academic Search Complete, LILACS and Academic Google in order to know the state of the art of DIC around the world. Regarding to a timeline, the first European DIC was created in 1960 and studies that described local situation were identified in 1996 and 2001. Thereafter, in the United States the first DIC was created in 1962 and 3 studies that describe DIC characteristics and changes trough time were identified between 2003 and 2008. Moreover, DICs were created in Singapore in 1980 and in Venezuela in 1981. In India was created a DIC in 1997. Subsequently, the WHO performed workshops in 2006 in order to create new centers in this country. In Asia was conducted a study in 1996 that identified 4 DIC. Concerning Latin America were found studies that describe local DIC from Brazil (2001) and Costa Rica (2003). Also, the network of Latin American and Caribbean DICs (REDCIMLAC) was created in 2011. In all consulted studies the DICs features were described including type of questions, professionals and infrastructure among others. Some of these studies included a comparison with the WHO technical document.
Los Centros de Información de Medicamentos (CIM) ocupan un lugar importante en el proceso de atención en salud al proporcionar información independiente y actualizada. Con el fin de conocer el estado del arte de los CIMs alrededor del mundo, se desarrolló una búsqueda en las bases de datos Medline, Science Direct, Academic Search Complete, LILACS y en Google Académico. Revisando cronológicamente la creación de CIMs, se encontró que el primero fue fundado en Europa en 1960. Posteriormente, se crearon en Estados Unidos en 1962, Singapur, 1980 y Venezuela, 1981. En India se fundó un CIM en 1997, posteriormente la OMS dictó talleres en ese país para fortalecer la creación de nuevos CIMs en 2006. En Asia se realizó un estudio en 1996 que identificó cuatro CIMs. En cuanto a Latinoamérica, se encontraron estudios de Brasil (2001) y Costa Rica (2003) que describen los CIMs locales. Adicionalmente, en 2011, se creó la red de CIMs de Latinoamérica y el Caribe (REDCIMLAC). En todos los estudios consultados se identificaron características de funcionamiento de los CIMs, como infraestructura, tipo de consultas, personal, entre otras. Algunos de estos estudios incluyeron una comparación con el documento técnico de la OMS.
RESUMO
OBJECTIVE: To discuss the working pattern and key points for pharmacists to carry out pharmaceutical care.METHODS: The working contents and working pattern of pharmacists were summarized by reviewing the experience of pharmacists in carrying out pharmaceutical care in certain departments in our hospital. RESULTS & CONCLUSION: To carry out clinical pharmaceutical care service,clinical pharmacists should actively participating in clinical work by giving monitoring on prescriptions,drug interaction,ADR and nutritional support,and communication with patients etc.